Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.94% |
| 2 | Technology | 8.23% |
| 3 | Healthcare | 7.53% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LND
5601
BrasilAgro
LND
$370M
| $77K | ﹤0.01% |
+13,477
| New | +$74.8K |
|
|
OKUR
5602
OnKure Therapeutics
OKUR
$155M
| $77K | ﹤0.01% |
3,306
-437
| -12% | -$11.6K |
|
|
MAPS
5603
DELISTED
WM TECHNOLOGY INC A
MAPS
| $76K | ﹤0.01% |
75,347
+36,071
| +92% | +$52.1K |
|
5604
CALL
Realty Income
O
$58.5B
| $76K | ﹤0.01% |
+136,300
| New | +$8.46M |
|
|
SFT
5605
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $76K | ﹤0.01% |
50,889
+17,892
| +54% | +$68K |
|
5606
Achieve Life Sciences
ACHV
$842M
| $75K | ﹤0.01% |
+30,422
| New | +$78.1K |
|
5607
Galmed Pharmaceuticals
GLMD
$4.48M
| $75K | ﹤0.01% |
104
+71
| +215% | +$37.2K |
|
5608
NanoViricides
NNVC
$32.7M
| $75K | ﹤0.01% |
67,346
+25,012
| +59% | +$39K |
|
|
TEAD
5609
Teads Holding Co
TEAD
$46.3M
| $75K | ﹤0.01% |
20,825
-13,389
| -39% | -$52.4K |
|
|
TIGR
5610
UP Fintech Holding
TIGR
$910M
| $75K | ﹤0.01% |
+22,040
| New | +$95.4K |
|
|
LOGC
5611
DELISTED
ContextLogic
LOGC
| $75K | ﹤0.01% |
+5,096
| New | +$105K |
|
5612
CALL
Alvotech Warrant
ALVOW
$115M
| $74K | ﹤0.01% |
69,711
| – | – |
|
|
CODX
5613
Co-Diagnostics
CODX
$8.8M
| $74K | ﹤0.01% |
985
-1,077
| -52% | -$101K |
|
5614
MeiraGTx Holdings
MGTX
$1.36B
| $74K | ﹤0.01% |
11,315
-47,230
| -81% | -$324K |
|
|
RDHL
5615
Redhill Biopharma
RDHL
$3.83M
| $74K | ﹤0.01% |
529
-95
| -15% | -$41.1K |
|
|
ACHL
5616
DELISTED
Achilles Therapeutics
ACHL
| $74K | ﹤0.01% |
+81,755
| New | +$138K |
|
|
CNTG
5617
DELISTED
Centogene N.V. Common Shares
CNTG
| $74K | ﹤0.01% |
77,146
+3,133
| +4% | +$2.85K |
|
|
BTMDW
5618
CALL
DELISTED
Biote Corp. Warrant
BTMDW
| $74K | ﹤0.01% |
245,602
-2,929
| -1% | -$798 |
|
|
ASPU
5619
DELISTED
ASPEN GROUP, INC.
ASPU
| $74K | ﹤0.01% |
239,571
+200,669
| +516% | +$72.7K |
|
5620
Planet Labs
PL
$7.54B
| $73K | ﹤0.01% |
16,838
-515,474
| -97% | -$2.67M |
|
|
SYBX
5621
DELISTED
Synlogic
SYBX
| $73K | ﹤0.01% |
6,362
+4,895
| +334% | +$59.7K |
|
|
YARW
5622
Yarrow Bioscience
YARW
$101M
| $73K | ﹤0.01% |
542
+321
| +145% | +$64.1K |
|
|
THER
5623
DELISTED
THERATECHNOLOGIES INC COM
THER
| $73K | ﹤0.01% |
80,868
+70,200
| +658% | +$63.4K |
|
5624
Hydrofarm Holdings
HYFM
$4.29M
| $72K | ﹤0.01% |
4,661
+3,531
| +312% | +$80.7K |
|
|
NEWP
5625
New Pacific Metals
NEWP
$1.37B
| $72K | ﹤0.01% |
32,602
-42,998
| -57% | -$96.9K |
|
Similar funds
Israel Englander's Q4 2022 Portfolio in Review
As of Q4 2022, Israel Englander held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander's Q4 2022 filing shows 848 new, 2,516 increased, 2,491 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Israel Englander added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Israel Englander's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Israel Englander fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Israel Englander's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Israel Englander opened 848 new positions and closed 1,332 in Q4 2022.
- Israel Englander's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.